70
Participants
Start Date
March 1, 2019
Primary Completion Date
October 31, 2019
Study Completion Date
October 31, 2019
Letrozole 2.5mg
These patients were treated with letrozole (Femara®, Novartis New York, NY, USA) in a dose 2.5 mg (one tablet daily) orally began on the 3rd day to the 7th day of the cycle. If ovulation is not achieved dose is increased by 2.5 mg in next cycle till 3 cycles
Gonadotropin
These patients were given urofollitropin (fostimon ®, IBSA, Lugano, Switzerland) in a dose of 75 IU/mL I.M from day 3rd to day 7th of the cycle beginning by one ampoule per day and the dose had been modulated according to response.
Ayman Shehata Dawood, Tanta
Tanta University
OTHER